Sevoflurano tópico e injertos en sello precoces y secuenciales en úlceras arterioloscleróticasuna serie de casos

  1. José Navarro Pascual 1
  2. Elena Conde-Montero 2
  3. Kevin Díez Madueño 2
  4. Alicia Peral Vázquez 2
  5. Pablo de la Cueva Dobao 2
  6. Alfredo Abad Gurumeta 2
  1. 1 Hospital Reina Sofía de Murcia
  2. 2 Hospital Universitario Infanta Leonor y Virgen de la Torre, Madrid
Journal:
MPJ Multidisciplinary Pain Journal

ISSN: 2697-2263

Year of publication: 2023

Issue: 1

Type: Article

More publications in: MPJ Multidisciplinary Pain Journal

Abstract

Introduction: Leg ulcers secondary to arteriolosclerosis may be included in the clinic- histopathological spectrum of Martorell hypertensive ischemic ulcer. Consequently, they could be considered to benefit from the same treatment. Early punch grafting is an effective technique for pain control and healing promotion in Martorell ulcer. Moreover, the off-label use of topical sevoflurane has been described to be beneficial both in pain control and wound epithelization. We present the first case series of arteriolosclerotic ulcers managed with combined use of topical sevoflurane and early and sequential punch grafting. Patients and methods: Patients with arteriolosclerotic ulcers treated with topical sevoflurane and punch grafting and adapted compression therapy at Hospital Virgen de la Torre from July 2021 to January 2022 were included in a case series. The primary endpoint was time to complete epithelialization and several secondary variables were registered. A Likert scale was used to measure pain. The presentation of the results is descriptive. Results: Five patients were recruited, all of them female sex, aged between 67 and 84 years. They associated comorbidities such as hypertension, diabetes mellitus and chronic venous insufficiency, with an evolution time from 2 weeks and 8 months. Hospital admission was performed in all cases and all of them received at least two treatment sessions with punch grafting. The time interval until complete epithelialisation of the ulcers ranged from 6 weeks to 6 months. When asked, all patients reported that pain had decreased significantly since the grafting were placed, even the next day. Discussion: The results of our study show how the combination of irrigated sevoflurane, compression therapy and stamp grafts is an effective combination to reduce pain and promote epithelialization of arteriolosclerosis ulcers. This treatment, which can be performed on an outpatient basis, is well tolerated by patients and can be repeated several times if necessary.

Bibliographic References

  • Monfort JB, Cury K, Moguelet P, Chasset F, Bachmeyer C, Francès C, et al. Cutaneous Arteriolosclerosis Is Not Specific to Ischemic Hypertensive Leg Ulcers. Dermatology. 2018;234(5-6):194-7. DOI: 10.1159/000492669.
  • Haute Autorité de Santé (HAS). Prise en charge de l’ulcère de jambe à prédominance veineuse hors pansement [Internet]. HAS; 2006. Disponible en http://www.hassante.fr/portail/jcms/c_459541/prise-en-charge-de-lulcere-de-jambe-a-predominanceveineuse-hors-pansement
  • Nordström A, Hansson C. Punch-grafting to enhance healing and to reduce pain in complicated leg and foot ulcers. Acta Derm Venereol 2008;88(4):389-91.
  • Fourgeaud C, Mouloise G, Michon-Pasturel U, Bonhomme S, Lazareth I, Meaume S, et al. Interest of punch skin grafting for the treatment of painful ulcers. J Mal Vasc. 2016;41(5):329-34. DOI: 10.1016/j.jmv.2016.08.002.
  • Guisado Muñoz S, Conde Montero E, de la Cueva Dobao P. Punch Grafting for the Treatment of Martorell Hypertensive Ischemic Leg Ulcer. Actas Dermosifiliogr. 2019;110(8):689-90. DOI: 10.1016/j.ad.2018.06.016.
  • Conde Montero E, Guisado Muñoz S, Pérez Jerónimo L, Peral Vazquez A, Montoro Lopez JJ, Hocajada Reales C, et al. Martorell Hypertensive Ischemic Ulcer Successfully Treated With Punch Skin Grafting. Wounds. 2018;30(2):E9-E12.
  • Conde-Montero E, Pérez Jerónimo L, Peral Vázquez A, Recarte Marín L, Sanabria Villarpando PE, de la Cueva Dobao P. Early and Sequential Punch Grafting in the Spectrum of Arteriolopathy Ulcers in the Elderly. Wounds. 2020;32(8):E38-E41.
  • Dámaso Fernández-Ginés F, Cortiñas-Sáenz M, Mateo-Carrasco H, de Aranda AN, Navarro-Muñoz E, Rodríguez-Carmona R, et al. Efficacy and safety of topical sevoflurane in the treatment of chronic skin ulcers. Am J Health Syst Pharm. 2017;74(9):e176-e182. DOI: 10.2146/ajhp151008.
  • Gerónimo Pardo M, Martinez Serrano M, Martínez Molsalve A, Rueda Martínez JL. Usos alternativos del sevoflurano. Efecto analgésico tópico. Rev Electron Anestesia. 2012;4:181.
  • Imbernón A, Blázquez C, Puebla A, Churruca M, Lobato A, Martínez M, et al. Chronic venous ulcer treatment with topical sevoflurane. Int Wound J. 2016;13(5):1060-2. DOI: 10.1111/iwj.12474.
  • Rock KL, Kono H. The inflammatory response to cell death. Annu Rev Pathol. 2008;3:99-126. DOI: 10.1146/annurev.pathmechdis.3.121806.151456.
  • Isoherranen K, O’Brien JJ, Barker J, Dissemond J, Hafner J, Jemec GBE, et al. Atypical wounds. Best clinical practice and challenges. J Wound Care. 2019;28(Sup6):S1-S92. DOI: 10.12968/jowc.2019.28.Sup6.S1.
  • Vuerstaek JD, Vainas T, Wuite J, Nelemans P, Neumann MH, Veraart JC. State-of-the-art treatment of chronic leg ulcers: A randomized controlled trial comparing vacuum-assisted closure (V.A.C.) with modern wound dressings. J Vasc Surg. 2006;44(5):1029-37. DOI: 10.1016/j.jvs.2006.07.030.